Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

RNA-sequencing analysis of 5' capped RNAs identifies many new differentially expressed genes in acute hepatitis C virus infection.

Papic N, Maxwell CI, Delker DA, Liu S, Heale BS, Hagedorn CH.

Viruses. 2012 Apr;4(4):581-612. doi: 10.3390/v4040581. Epub 2012 Apr 16.

2.

ENCODE tiling array analysis identifies differentially expressed annotated and novel 5' capped RNAs in hepatitis C infected liver.

Folkers ME, Delker DA, Maxwell CI, Nelson CA, Schwartz JJ, Nix DA, Hagedorn CH.

PLoS One. 2011 Feb 16;6(2):e14697. doi: 10.1371/journal.pone.0014697.

3.

Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus.

Blackham S, Baillie A, Al-Hababi F, Remlinger K, You S, Hamatake R, McGarvey MJ.

J Virol. 2010 May;84(10):5404-14. doi: 10.1128/JVI.02529-09. Epub 2010 Mar 3.

4.

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V.

J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.

5.

Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA.

Sejima H, Mori K, Ariumi Y, Ikeda M, Kato N.

Virus Res. 2012 Jul;167(1):74-85. doi: 10.1016/j.virusres.2012.04.008. Epub 2012 May 1.

6.

A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.

Sa-Ngiamsuntorn K, Wongkajornsilp A, Phanthong P, Borwornpinyo S, Kitiyanant N, Chantratita W, Hongeng S.

Virol J. 2016 Apr 5;13:59. doi: 10.1186/s12985-016-0519-1.

7.

Moonlighting glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is required for efficient hepatitis C virus and dengue virus infections in human Huh-7.5.1 cells.

Raj M, Langley M, McArthur SJ, Jean F.

J Gen Virol. 2017 May;98(5):977-991. doi: 10.1099/jgv.0.000754. Epub 2017 May 26.

PMID:
28548037
8.

Hepatitis C virus infection induces the expression of amphiregulin, a factor related to the activation of cellular survival pathways and required for efficient viral assembly.

Pei R, Chen H, Lu L, Zhu W, Beckebaum S, Cicinnati V, Lu M, Chen X.

J Gen Virol. 2011 Oct;92(Pt 10):2237-48. doi: 10.1099/vir.0.032581-0. Epub 2011 Jun 8.

PMID:
21653755
9.

Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones.

Ciccaglione AR, Marcantonio C, Tritarelli E, Tataseo P, Ferraris A, Bruni R, Dallapiccola B, Gerosolimo G, Costantino A, Rapicetta M.

BMC Genomics. 2008 Jun 30;9:309. doi: 10.1186/1471-2164-9-309.

10.

Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines.

Takeda M, Ikeda M, Ariumi Y, Wakita T, Kato N.

J Gen Virol. 2012 Jul;93(Pt 7):1422-31. doi: 10.1099/vir.0.040725-0. Epub 2012 Mar 28.

11.

Ankyrin Repeat Domain 1 is Up-regulated During Hepatitis C Virus Infection and Regulates Hepatitis C Virus Entry.

Than TT, Tran GV, Son K, Park EM, Kim S, Lim YS, Hwang SB.

Sci Rep. 2016 Feb 10;6:20819. doi: 10.1038/srep20819.

12.

Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.

Abe Y, Aly HH, Hiraga N, Imamura M, Wakita T, Shimotohno K, Chayama K, Hijikata M.

Gastroenterology. 2013 Sep;145(3):658-67.e11. doi: 10.1053/j.gastro.2013.05.014. Epub 2013 May 16.

PMID:
23684750
13.

Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.

Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, Locarnini SA, Beard MR.

J Hepatol. 2009 Sep;51(3):446-57. doi: 10.1016/j.jhep.2009.04.025. Epub 2009 Jun 3.

PMID:
19596477
14.

Genome-wide analysis of host mRNA translation during hepatitis C virus infection.

Colman H, Le Berre-Scoul C, Hernandez C, Pierredon S, Bihouée A, Houlgatte R, Vagner S, Rosenberg AR, Féray C.

J Virol. 2013 Jun;87(12):6668-77. doi: 10.1128/JVI.00538-13. Epub 2013 Apr 3. Erratum in: J Virol. 2016 May 27;90(12 ):5846.

15.

Epigenetic silencing of antiviral genes renders clones of Huh-7 cells permissive for hepatitis C virus replication.

Chen Q, Denard B, Huang H, Ye J.

J Virol. 2013 Jan;87(1):659-65. doi: 10.1128/JVI.01984-12. Epub 2012 Oct 31.

16.

ISG56 and IFITM1 proteins inhibit hepatitis C virus replication.

Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray RB.

J Virol. 2011 Dec;85(24):12881-9. doi: 10.1128/JVI.05633-11. Epub 2011 Oct 5.

17.

Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.

Sun LJ, Yu JW, Wan L, Zhang XY, Shi YG, Chen MY.

Int J Infect Dis. 2014 Jun;23:75-81. doi: 10.1016/j.ijid.2013.12.017. Epub 2014 Apr 2.

18.
19.

Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.

Mukherjee A, Di Bisceglie AM, Ray RB.

J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.

20.

Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.

Mitchell AM, Stone AE, Cheng L, Ballinger K, Edwards MG, Stoddard M, Li H, Golden-Mason L, Shaw GM, Khetani S, Rosen HR.

MBio. 2015 Feb 24;6(2):e02510. doi: 10.1128/mBio.02510-14.

Supplemental Content

Support Center